releases: https://hoyle.house.gov/media/press-releases/rep-hoyle-calls-on-fda-to-take-action-around-estrogen-patch-shortage
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://hoyle.house.gov/media/press-releases/rep-hoyle-calls-on-fda-to-take-action-around-estrogen-patch-shortage | REP. HOYLE CALLS ON FDA TO TAKE ACTION AROUND ESTROGEN PATCH SHORTAGE | 2026-09-29 | 2026 | 2026-09 | Democrat | House | OR | Val T. Hoyle | H001094 | hoyle.house.gov | hoyle | https://hoyle.house.gov/media/press-releases | scraper | EUGENE, OR – Today, Representative Val Hoyle (OR-04), released the following statement after joining her colleagues in the Democratic Women’s Caucus in sending a letter to the U.S. Food and Drug Administration (FDA) demanding they treat the ongoing Estradiol patch supply disruption with the urgency it deserves: "Women across the country can't get their prescriptions filled and aren't given answers why," said Rep. Hoyle. "This isn't just an inconvenience; it's a direct threat to their long-term health. This Administration cannot keep looking the other way while women's health is sidelined. The FDA must treat this crisis with the urgency it needs." Background: Estradiol patches are used by millions of peri- and post-menopausal individuals to manage menopause symptoms and protect long-term health, including bone density. In 2025, the removal of the black box warning on menopausal hormone therapy products contributed to a significant increase in prescriptions at a time when manufacturing capacity was already strained. This surge has outpaced the supply chain’s ability to keep pace. Patients nationwide have been reporting significant difficulties filling estradiol patch prescriptions. Treatment interruptions can mean the return of debilitating symptoms and for some, real risk to their long-term bone and cardiovascular health. 44 Cosigners: Ansari, Yassamin; Barragán, Nanette; Bonamici, Suzanne; Clarke, Yvette; Dexter, Maxine; Dingell, Debbie; Escobar, Veronica; Fletcher, Lizzie; Frankel, Lois; Friedman, Laura; Garcia, Sylvia; Gillen, Laura; Grijalva, Adelita; Hayes, Jahana; Houlahan, Chrissy; Hoyle, Val; Jayapal, Pramila; Johnson, Julie; Kamlager-Dove, Sydney; Leger Fernandez, Teresa; McClain Delaney, April; McIver, LaMonica; Morrison, Kelly; Pettersen, Brittany; Pingree, Chellie; Pou, Nellie; Pressley, Ayanna; Ramirez, Delia; Randall, Emily; Rivas, Luz; Ross, Deborah; Salinas, Andrea; Scholten, Hillary; Simon, Lateefah; Stansbury, Melanie; Stevens, Haley; Tlaib, Rashida; Tokuda, Jill; Trahan, Lori; Velázquez, Nydia; Waters, Maxine; Watson Coleman, Bonnie; Williams, Nikema; Wilson, Frederica. | 1 | 2026-09-30T10:57:52Z | 2026-09-30T10:59:04Z |